Meeting
2022 ASCO Annual Meeting
African American patients with smoldering multiple myeloma may have a lower risk of progression compared to White patients.
Authors
Theresia Akhlaghi
Department of Internal Medicine, Icahn School of Medicine, Mount Sinai Morningside and West, New York, NY
Theresia Akhlaghi , Kylee Maclachlan , Neha Korde , Sham Mailankody , Alexander M. Lesokhin , Hani Hassoun , Sydney X. Lu , Dhwani Patel , Urvi A Shah , Carlyn Tan , Andriy Derkach , Oscar Boutros Lahoud , Heather Jolie Landau , Gunjan L. Shah , Michael Scordo , David J. Chung , Sergio Giralt , Saad Zafar Usmani , Carl Ola Landgren , Malin Hultcrantz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies
Sub Track
Multiple Myeloma
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 8045)
DOI
10.1200/JCO.2022.40.16_suppl.8045
Abstract #
8045
Poster Bd #
469
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Evaluating serum-free light chain ratio as a biomarker for multiple myeloma.
First Author: Theresia Akhlaghi
Poster
2017 ASCO Annual Meeting
The impact of body mass index on the risk of early progression of smoldering multiple myeloma to symptomatic myeloma.
First Author: Wilson I. Gonsalves
Poster
2017 ASCO Annual Meeting
Risk stratification of smoldering multiple myeloma (SMM): Predictive value of free light chains and group-based trajectory modeling (GBTM).
First Author: Ajai Chari
Poster
2016 ASCO Annual Meeting
Association of abnormal molecular markers with clonal plasma cell burden in light chain amyloidosis.
First Author: Lindsay Hammons